Osteoporosis, Androgen Levels and Urological Care-Reference-Cited by-同舟云学术

Osteoporosis, Androgen Levels and Urological Care

Published:2010-06 Issue:6 Volume:183 Page:2122-2123
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Adler Robert A.¹

Affiliation:

1. Endocrinology and Metabolism Section, McGuire Veterans Affairs Medical Center, Departments of Internal Medicine and Epidemiology and Community Health, Virginia Commonwealth University School of Medicine, Richmond, Virginia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference8 articles.

1. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX;Adler;Osteoporos Int,2010

2. Risk of fracture after androgen deprivation therapy for prostate cancer;Shahinian;N Engl J Med,2005

3. Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition;Smith;J Clin Oncol,2004

4. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer;Smith;J Urol,2003

5. Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study;Smith;J Urol,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy;Journal of the American Association of Nurse Practitioners;2014-01